Sona Nanotech Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SNANF research report →
About the company
Sona Nanotech Inc. is a life sciences enterprise specializing in nanotechnology, primarily engaged in the development and commercialization of gold nanorod products for diagnostic purposes. The company's offerings also encompass distinct gold nanorod varieties, such as Gemini and Omni (the latter tailored specifically for medical uses), alongside providing specialized contract services.
- CEO
- David Andrew Regan
- IPO
- 2006
- Employees
- 8
- HQ
- Halifax, NS, CA
Price Chart
- Market Cap
- $36.03M
- P/E
- -11.57
- P/S
- 0.00
- P/B
- -44.85
- EV/EBITDA
- -14.55
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 1894.66%
- ROIC
- 694.57%
- Revenue
- $0 · 0.00%
- Net Income
- $-3,249,908 · -20.19%
- EPS
- $-0.03 · -7.43%
- Op Income
- $-3,441,821
- FCF YoY
- -0.05%
- 52W High
- $0.65
- 52W Low
- $0.19
- 50D MA
- $0.22
- 200D MA
- $0.32
- Beta
- 0.98
- Avg Volume
- 7.31K
Get TickerSpark's AI analysis on SNANF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our SNANF coverage
Recent articles, reports, and earnings notes.
No research on SNANF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SNANF report →Similar companies
Peers in the same neighborhood.